Cargando…
Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures
In the United States, federally-funded health plans are mandated to measure the quality of care. Adherence-based medication quality metrics depend on completeness of administrative claims data for accurate measurement. Low-cost generic programs (LCGPs) cause medications fills to be missing from clai...
Autores principales: | Pauly, Nathan J., Talbert, Jeffery C., Brown, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419384/ https://www.ncbi.nlm.nih.gov/pubmed/28970427 http://dx.doi.org/10.3390/pharmacy5010015 |
Ejemplares similares
-
The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population
por: Pauly, Nathan James, et al.
Publicado: (2015) -
The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population
por: Brown, Joshua D., et al.
Publicado: (2016) -
Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data
por: Pauly, Nathan J., et al.
Publicado: (2016) -
Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults
por: Pauly, Nathan James, et al.
Publicado: (2015) -
Prescription Drug Costs and the Generic Dispensing Ratio
por: Liberman, Joshua N., et al.
Publicado: (2010)